{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T07:20:00Z","timestamp":1789370400743,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004212","name":"P\u00e4ivikki and Sakari Sohlberg Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004212","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"NIMH","doi-asserted-by":"publisher","award":["P50MH094268"],"award-info":[{"award-number":["P50MH094268"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","schres-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.schres.2017.06.052","type":"journal-article","created":{"date-parts":[[2017,7,12]],"date-time":"2017-07-12T10:45:32Z","timestamp":1499856332000},"page":"329-335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["The association between toxoplasma and the psychosis continuum in a general population setting"],"prefix":"10.1016","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9846-0416","authenticated-orcid":false,"given":"Maija","family":"Lindgren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minna","family":"Torniainen-Holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommi","family":"H\u00e4rk\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faith","family":"Dickerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Yolken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7167-0990","authenticated-orcid":false,"given":"Jaana","family":"Suvisaari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.schres.2017.06.052_bb0005","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.biopsych.2006.09.034","article-title":"Antibodies to infectious agents in individuals at ultra-high risk for psychosis","volume":"61","author":"Amminger","year":"2007","journal-title":"Biol. Psychiatry."},{"key":"10.1016\/j.schres.2017.06.052_bb0010","series-title":"Baseline Results of the Health 2000 Health Examination Survey","first-page":"2004","article-title":"Health and functional capacity in Finland","volume":"B12","author":"Aromaa","year":"2004"},{"issue":"1\u20132","key":"10.1016\/j.schres.2017.06.052_bb0015","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0920-9964(02)00336-5","article-title":"How false are \u201cfalse\u201d positive psychotic symptoms?","volume":"62","author":"Bak","year":"2003","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.schres.2017.06.052_bb0020","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/schbul\/sbm005","article-title":"Toxoplasma gondii in individuals with schizophrenia: association with clinical and demographic factors and with mortality","volume":"33","author":"Dickerson","year":"2007","journal-title":"Schizophr. Bull."},{"issue":"4","key":"10.1016\/j.schres.2017.06.052_bb0025","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s11011-016-9822-1","article-title":"The known and missing links between Toxoplasma gondii and schizophrenia","volume":"31","author":"Elsheikha","year":"2016","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.schres.2017.06.052_bb0030","series-title":"Structured Clinical Interview for DSM-IV Axis I Disorders, Research Version, Nonpatient Edition (SCID-I\/NP)","author":"First","year":"1997"},{"issue":"2","key":"10.1016\/j.schres.2017.06.052_bb0035","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.0006-341X.1999.00652.x","article-title":"Predictive margins with survey data","volume":"55","author":"Graubard","year":"1999","journal-title":"Biometrics"},{"issue":"3","key":"10.1016\/j.schres.2017.06.052_bb0040","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ejca.2010.07.032","article-title":"C-reactive protein-associated genetic variants and cancer risk: findings from FINRISK 1992, FINRISK 1997 and health 2000 studies","volume":"47","author":"Heikkil\u00e4","year":"2011","journal-title":"Eur. J. Cancer."},{"issue":"2","key":"10.1016\/j.schres.2017.06.052_bb0045","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000092251","article-title":"Infectious burden as a determinant of atopy\u2014a comparison between adults in Finnish and Russian Karelia","volume":"140","author":"von Hertzen","year":"2006","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"6","key":"10.1016\/j.schres.2017.06.052_bb0050","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1177\/1040638712461787","article-title":"Feline toxoplasmosis in Finland: cross-sectional epidemiological study and case series study","volume":"24","author":"Jokelainen","year":"2012","journal-title":"J. Vet. Diagn. Invest."},{"issue":"3","key":"10.1016\/j.schres.2017.06.052_bb0055","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/schbul\/22.3.511","article-title":"Self-report measures of schizotypy as indices of familial vulnerability to schizophrenia","volume":"22","author":"Kendler","year":"1996","journal-title":"Schizophr. Bull."},{"issue":"7","key":"10.1016\/j.schres.2017.06.052_bb0060","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1001\/jamapsychiatry.2015.0575","article-title":"Psychotic experiences in the general population: a cross-national analysis based on 31,261 respondents from 18 countries","volume":"72","author":"McGrath","year":"2015","journal-title":"JAMA Psychiat."},{"issue":"3","key":"10.1016\/j.schres.2017.06.052_bb0065","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/schbul\/sbq099","article-title":"The continuum of psychotic symptoms in the general population: a cross-national study","volume":"38","author":"Nuevo","year":"2012","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.schres.2017.06.052_bb0070","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1017\/S0033291708003814","article-title":"A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder","volume":"39","author":"van Os","year":"2009","journal-title":"Psychol. Med."},{"issue":"8","key":"10.1016\/j.schres.2017.06.052_bb0075","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1176\/appi.ajp.2011.10091351","article-title":"Toxoplasma infection and later development of schizophrenia in mothers","volume":"168","author":"Pedersen","year":"2011","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2017.06.052_bb0080","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archpsyc.64.1.19","article-title":"Lifetime prevalence of psychotic and bipolar I disorders in a general population","volume":"64","author":"Per\u00e4l\u00e4","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2017.06.052_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00127-005-0848-7","article-title":"DSM-IV mood-, anxiety- and alcohol use disorders and their comorbidity in the Finnish general population\u2014results from the health 2000 study","volume":"40","author":"Pirkola","year":"2005","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"issue":"3","key":"10.1016\/j.schres.2017.06.052_bb0090","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.eurpsy.2015.01.010","article-title":"EPA guidance on the early detection of clinical high risk states of psychoses","volume":"30","author":"Schultze-Lutter","year":"2015","journal-title":"Eur. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2017.06.052_bb0095","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.schres.2014.06.027","article-title":"Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling","volume":"176","author":"Severance","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2017.06.052_bb0100","article-title":"Curiosity killed the cat: no evidence of an association between cat ownership and psychotic symptoms at ages 13 and 18years in a UK general population cohort","volume":"1\u20139","author":"Solmi","year":"2017","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2017.06.052_bb0105","series-title":"Stata Statistical Software: Release 11","author":"StataCorp","year":"2009"},{"issue":"2","key":"10.1016\/j.schres.2017.06.052_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148435","article-title":"Is Toxoplasma gondii infection related to brain and behavior impairments in humans? Evidence from a population-representative birth cohort","volume":"11","author":"Sugden","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.schres.2017.06.052_bb0115","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/acps.12423","article-title":"Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis","volume":"132","author":"Sutterland","year":"2015","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2017.06.052_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2017.07.020","article-title":"Toxoplasma gondii infection and common mental disorders in the Finnish general population","author":"Suvisaari","year":"2017","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.schres.2017.06.052_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2015.03.036","article-title":"Is childhood cat ownership a risk factor for schizophrenia later in life?","volume":"165","author":"Torrey","year":"2015","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2017.06.052_bb0130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.schres.2011.03.013","article-title":"Antibodies to infectious agents and the positive symptom dimension of subclinical psychosis: the TRAILS study","volume":"129","author":"Wang","year":"2011","journal-title":"Schizophr. Res."},{"issue":"11","key":"10.1016\/j.schres.2017.06.052_bb0135","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s001270050095","article-title":"Test-retest reliability of the computerized DSM-IV version of the Munich-Composite International Diagnostic Interview (M-CIDI)","volume":"33","author":"Wittchen","year":"1998","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"issue":"4","key":"10.1016\/j.schres.2017.06.052_bb0140","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/apha.12458","article-title":"Strain hypothesis of Toxoplasma gondii infection on the outcome of human diseases","volume":"213","author":"Xiao","year":"2015","journal-title":"Acta Physiol (Oxf.)"},{"issue":"5","key":"10.1016\/j.schres.2017.06.052_bb0145","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/mp.2008.5","article-title":"Are some cases of psychosis caused by microbial agents? A review of the evidence","volume":"13","author":"Yolken","year":"2008","journal-title":"Mol. Psychiatry"},{"issue":"11","key":"10.1016\/j.schres.2017.06.052_bb0150","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1365-3024.2009.01131.x","article-title":"Toxoplasma and schizophrenia","volume":"31","author":"Yolken","year":"2009","journal-title":"Parasite Immunol."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996417303912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996417303912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T03:57:26Z","timestamp":1535601446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996417303912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":30,"alternative-id":["S0920996417303912"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2017.06.052","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association between toxoplasma and the psychosis continuum in a general population setting","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2017.06.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}